Bausch Lomb Ownership
| BLCO Stock | USD 19.67 0.10 0.51% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Bausch |
Bausch Stock Ownership Analysis
About 88.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.05. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bausch Lomb Corp has Price/Earnings To Growth (PEG) ratio of 0.7. The entity recorded a loss per share of 1.04. The firm had not issued any dividends in recent years. Bausch Lomb Corporation operates as an eye health company worldwide. The company was founded in 1853 and is headquartered in Vaughan, Canada. Bausch Lomb operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 12500 people. For more info on Bausch Lomb Corp please contact Brenton JD at (905) 695-7700 or go to https://www.bausch.com.Besides selling stocks to institutional investors, Bausch Lomb also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Bausch Lomb's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Bausch Lomb's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Bausch Lomb Quarterly Liabilities And Stockholders Equity |
|
About 88.0% of Bausch Lomb Corp are currently held by insiders. Unlike Bausch Lomb's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Bausch Lomb's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Bausch Lomb's insider trades
Bausch Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Bausch Lomb is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bausch Lomb Corp backward and forwards among themselves. Bausch Lomb's institutional investor refers to the entity that pools money to purchase Bausch Lomb's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Mangrove Partners | 2024-06-30 | 1.2 M | Laurion Capital Management Lp | 2024-09-30 | 1 M | Exoduspoint Capital Management, Lp | 2024-09-30 | 924.5 K | Canada Pension Plan Investment Board | 2024-09-30 | 851.7 K | Clearline Capital Lp | 2024-09-30 | 710.1 K | Clark Estates Inc | 2024-09-30 | 687.5 K | Caspian Capital Partners, L.p. | 2024-09-30 | 650 K | Bridger Management Llc | 2024-09-30 | 506.3 K | Citadel Advisors Llc | 2024-09-30 | 391.6 K | Fidelity International Ltd | 2024-06-30 | 6.7 M | Maple Rock Capital Partners, Inc. | 2024-06-30 | 3.7 M |
Bausch Lomb Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bausch Lomb insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bausch Lomb's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bausch Lomb insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Bausch Lomb Outstanding Bonds
Bausch Lomb issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bausch Lomb Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bausch bonds can be classified according to their maturity, which is the date when Bausch Lomb Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Bausch Lomb Corporate Filings
8K | 1st of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 4th of October 2024 Other Reports | ViewVerify | |
F4 | 1st of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 1st of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Pair Trading with Bausch Lomb
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Lomb position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Lomb will appreciate offsetting losses from the drop in the long position's value.Moving against Bausch Stock
| 0.85 | FORA | Forian Inc | PairCorr |
| 0.74 | IVP | Inspire Veterinary | PairCorr |
| 0.6 | AMN | AMN Healthcare Services | PairCorr |
| 0.57 | AGL | agilon health Buyout Trend | PairCorr |
| 0.54 | EVH | Evolent Health | PairCorr |
The ability to find closely correlated positions to Bausch Lomb could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Lomb when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Lomb - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Lomb Corp to buy it.
The correlation of Bausch Lomb is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Lomb moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Lomb Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Lomb can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Lomb Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Lomb. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Lomb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.89) | Earnings Share (1.04) | Revenue Per Share 13.327 | Quarterly Revenue Growth 0.188 | Return On Assets 0.0089 |
The market value of Bausch Lomb Corp is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Lomb's value that differs from its market value or its book value, called intrinsic value, which is Bausch Lomb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Lomb's market value can be influenced by many factors that don't directly affect Bausch Lomb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Lomb's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Lomb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Lomb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.